Background
==========

A lipid profile characterized by reduced high density lipoprotein-cholesterol (HDL-c) concentrations and increased low density lipoprotein-cholesterol (LDL-c) and triglycerides concentrations as well as increased total cholesterol-to-HDL-c ratio constitutes a high risk for type 2 diabetes, metabolic syndrome and cardiovascular diseases \[[@B1]-[@B3]\]. In turn, oxidative stress impairment or altered antioxidant status have been suggested as pivotal keys in the onset of certain chronic diseases \[[@B4],[@B5]\].

In this sense, oxidized low-density lipoproteins (ox-LDL), a recognized oxidative stress marker, has been positively associated with central obesity \[[@B6]\], metabolic syndrome manifestation \[[@B7]\] and atherosclerosis \[[@B8]\]. Also, uric acid has been proposed as independent risk factor for cardiovascular diseases \[[@B9],[@B10]\], in addition to implication in LDL-c oxidation and generation of an oxidative status in hyperuricemia conditions \[[@B11],[@B12]\]. In turn, glutathione peroxidase is an enzyme with relevant antioxidant role in the redox balance \[[@B4]\], while selenium is an essential mineral, which have been investigated by its antioxidant and anti-inflammatory proprieties in the preventing chronic disorders \[[@B13]-[@B15]\]. However, the relationship of ox-LDL with lipid and oxidative stress biomarkers has been only modestly investigated in young adult people \[[@B16]\], while its association with nail selenium levels has not been apparently reported.

Overall, this study aimed to assess plasma ox-LDL concentrations and the potential associations with oxidative stress markers as well as with anthropometric and metabolic (glucose and lipid profiles) data in healthy young adults. Thus, we measured plasma uric acid concentrations and glutathione peroxidase (GPx) activity in erythrocytes, since an altered regulation of these markers has been associated with ox-LDL concentrations in oxidative stress and chronic disorders conditions \[[@B11],[@B12],[@B17],[@B18]\]. Also, we also assessed nail levels of three trace elements related to antioxidant defense mechanisms (selenium, zinc and cooper), whose levels have presented relevant associations with biomarkers in young adults \[[@B13],[@B14],[@B19]\].

Subjects and methods
====================

Subjects
--------

In this study participated 160 subjects (92 women and 68 men) with a mean age of 23 ± 4 years old (range 18-35) and a mean body mass index (BMI) of 22.0 ± 2.9 kg/m^2^(range 18.5-34.9). Exclusion criteria were any diagnosed organic underlying disease (gastrointestinal, kidney, liver, respiratory or heart disease), cancer, infectious and inflammatory disorders, diabetes (fasting glucose level \> 126 mg/dl), hypertension (systolic and diastolic blood pressure values ≥ 140 and 90 mmHg, respectively), pregnancy, disorders affecting body composition (e.g. lipodystrophy and Cushing syndrome) or lipid-lowering treatment. Other exclusion criteria were contraceptive use up to 2 months before participation in this study, recent follow up of diets designed for weight loss or unstable weight (change \> 10% in habitual weight) in the past 6 months. In accordance with the principals of the Helsinki Declaration and after a clear explanation of the study protocol, each participant gave a written informed consent to participate. The study was approved by the Committee of Ethics in Research with Human Beings of the Federal University of Viçosa (Of. Ref. n° 009/2006).

Anthropometric and body composition assessments
-----------------------------------------------

Anthropometric and body composition were determined in all the subjects after 12 h of fasting. Body weight was measured with an electronic microdigital scale balance (Tanita TBF-300A model, Tokyo, Japan) to the nearest 0.1 kg, while height was assessed with a stadiometer (Seca 206 model, Hamburg, Germany) to the nearest 0.1 cm. Thus, BMI was calculated by the ratio between weight (kg) and the squared height (m^2^), which was applied to categorize normal-weight (18.5-24.9 kg/m^2^), overweight (25-29.9 kg/m^2^), and obese (BMI ≥30 kg/m^2^) subjects, according to the World Health Organization criteria \[[@B20]\]. Waist circumference was measured midway between the lowest rib and the iliac crest and hip circumference was determined at the maximal hip circumference without gluteus contraction \[[@B21]\], both with an inelastic and flexible tape to the nearest 0.1 cm. The waist-to-hip ratio was also calculated. Triceps, biceps, subscapular and suprailiac skinfold thicknesses (ST) were measured to the nearest 1 mm by using a skinfold caliper (Lange caliper, Cambridge Scientific Industries Inc., Cambridge Maryland, USA), according to a previously described protocol \[[@B22]\]. The sum of STs (mm) was also calculated. Truncal fat was also calculated as the sum of subscapular and suprailiac ST divided by the sum of 4 ST, expressed in percentage \[[@B13],[@B23]\]. Total body fat (%, to the nearest 0.1%) and body fat mass (kg) were measured by an impedance bioelectric device (Biodynamics 310 model, Washington, USA).

Blood pressure and biological sample measurements
-------------------------------------------------

Systolic and diastolic blood pressure values were measured twice by a mercury sphygmomanometer (BIC, São Paulo, Brazil) to the nearest 2 mmHg as described elsewhere \[[@B24]\].

Blood samples were draw by vein puncture after a 12 h overnight fast. The plasma and serum samples were separated from whole blood by centrifugation at 2465 *g*× 15 min at 5°C (Eppendorf AG, 5804R model, Hamburg, Germany) and were immediately stored at -80°C until assay. Serum glucose, total cholesterol, HDL-c, triacylglycerols, and uric acid concentrations were assessed by specific colorimetric assays (Bioclin, Quibasa, Minas Gerais, Brazil), using an automated analyzer system (BS-200, Shenzhen Mindray Bio-medical Electronics Co., Nanshan, China). LDL-c data were calculated by the Friedewald equation as described elsewhere \[[@B25]\]. The total cholesterol-to-HDL-c ratio was also calculated \[[@B26]\]. Plasma insulin concentrations (sensitivity 2 μU/mL) were measured by an ELISA assay kit (Linco Research, St. Charles, USA). Insulin resistance was estimated by the homeostasis model assessment of insulin resistance (HOMA-IR) calculated as fasting glucose (mmol/L) × fasting insulin (μU/mL)/22.5 \[[@B27]\]. Plasma ox-LDL concentrations (sensitivity \< 6.56 U/L) were measured by an ELISA assay kit (Mercodia, Uppsala, Sweden). GPx activity (nmol/\[mL/min\]) was measured in erythrocytes by a commercially available kit (Cayman Chemical, Ann Arbor, USA). Of total sample, 135 participants delivered fingernail and toenail samples as requested. Fingernail and toenail samples were treated with sub-boiling nitric acid in a high-pressure teflon digestion vessel using a microwave digestion system (Ethos Plus, Millestone, Sorisole, Italy). Selenium (ng/g of nail), copper and zinc (μg/g of nail) concentrations were measured by a Perkin Elmer Analyst 800 atomic absorption spectrometer (Norwalk, CT, USA) as previously described \[[@B28],[@B29]\].

Other lifestyle measurements
----------------------------

As covariates, lifestyle features were also determined. Thus, the participants were asked about smoking status (never, former, or current smokers) and, if it was the case, how many cigarettes they smoked per day. Also, they were requested whether some vitamin supplement was consumed (Yes/No). In respect to physical activity, the participants declared about to regular physical activity practice (Yes/No), and if it was the case, the type and the volume of activity (h/week). To quantify the volume of activity, a metabolic equivalent (MET) index was also computed by assigning a multiple of resting metabolic rate (MET score) to each activity \[[@B30]\], followed by the sum over all activities to obtain a value of overall weekly MET/h as described elsewhere \[[@B31]\].

Statistical analysis
--------------------

Results are shown as mean ± SD. The Kolmogorov-Smirnov normality test was used to determine variable distribution. In order to detect difference in anthropometrical, lifestyle, metabolic and oxidative stress data in respect to ox-LDL concentrations, this was taken as suitable variable considering its median as cutoff value (69.4 U/L) and categorizing the subsequent population group in \"low\" and \"high\" ox-LDL concentrations according to this value (\< or ≥ 69.4 U/L, respectively). The median cutoff criteria have been previously applied \[[@B13],[@B19]\] and is based on a valid and reliable method to assign two groups of risk in epidemiological studies \[[@B32]\]. Accordingly, statistical comparisons between groups were performed by the parametric Student *t*-test, Manny-Whitney *U*-test or chi-square (χ^2^) test as appropriate. The Spearman correlation coefficients were used to screen the potential associations between ox-LDL concentrations and interest variables. In addition, multivariate linear regression models were also applied to further explain the associations of ox-LDL concentrations with these variables. The linear regression models were adjusted for gender, age, smoking status, physical activity practice. Confidence intervals (95% CIs) were used to describe linear regression coefficient (β).

We also categorized the participants by tertiles of GPx activity, nail selenium levels, and uric acid concentrations, since these biomarkers were significantly associated with ox-LDL in the linear regression analyses previously described in this section. Linear trends were assessed by assigning the median value to each tertile of these variables and modeling these values as a continuous variable. Subsequently, we performed linear regression analyses, including ox-LDL as dependent variable, tertiles of GPx activity, nail selenium levels, and uric acid concentrations as independent variables, and gender, age, smoking status, physical activity practice, total cholesterol or LDL-c concentrations, truncal fat or BMI, and uric acid (in some cases) as control covariates. Since the GPx activity and selenium nail levels were measured in a fewer number of participants (n = 100 and n = 135, respectively), we tested *a posteriori*the statistical power (1-β) to trends of these markers with ox-LDL, using effect size f^2^(based in corrected R^2^values), *P*-value from model \< 0.05, total sample size and the number of independent predictors as input parameters, in the G\*Power version 3.0.10. A *P-*value \< 0.05 was considered statistically significant, and the statistical analyses were performed using SAS system 8.0 (SAS Institute Inc., Cary, USA).

Results
=======

Anthropometric, clinical and biochemical data (mean ± SD) categorized by the median value of plasma ox-LDL concentrations are reported in Table [1](#T1){ref-type="table"}. Individuals with high concentrations of ox-LDL (≥69.4 U/L) showed significantly higher values of BMI, total cholesterol, LDL-c, total cholesterol-to-HDL-c ratio, uric acid, and GPx activity, while nail selenium levels were significantly lower. Gender distribution, anthropometric and body composition measurements, except BMI, glucose profile, and blood pressure did not differ, when classified by ox-LDL concentrations. No differences were found concerning to lifestyle features, when categorized by the median value of ox-LDL concentrations (Table [2](#T2){ref-type="table"}).

###### 

Anthropometric, clinical, and biochemical data, categorized by the median (cutoff: 69.4 U/L) of ox-LDL concentrations (n = 160)

  -----------------------------------------------------------------------------------
                                        Low ox-LDL\     High ox-LDL\    *P*-value\*
                                        \<69.4 U/L\     ≥ 69.4 U/L\     
                                        (n = 80)        (n = 80)        
  ------------------------------------- --------------- --------------- -------------
  Women (%)                             60.8            52.6            0.305

  Age (y)                               23.1 ± 3.6      23.4 ± 3.4      0.145

  BMI (kg/m^2^)                         21.6 ± 2.8      22.4 ± 3.0      *0.046*

  Waist circumference (cm)              78.0 ± 8.7      78.3 ± 8.7      0.863

  Waist-to-hip ratio                    0.8 ± 0.1       0.8 ± 0.1       0.469

  Sum of 4 ST (mm)                      42.6 ± 16.8     45.0 ± 20.4     0.369

  Truncal fat (%)                       57.4 ± 7.1      59.3 ± 6.1      0.069

  Total body fat (%)                    23.8 ± 6.1      23.4 ± 7.0      0.735

  Body fat mass (kg)                    15.0 ± 5.2      14.7 ± 5.4      0.303

  Systolic blood pressure (mmHg)        109 ± 9         110 ± 9         0.239

  Diastolic blood pressure (mmHg)       74 ± 7          73 ± 7          0.257

  Glucose (mg/dL)                       90.8 ± 7.0      90.3 ± 6.3      0.394

  Insulin (μU/mL)\*\*                   10.3 ± 5.0      10.2 ± 6.0      0.302

  HOMA-IR\*\*                           2.3 ± 1.2       2.3 ± 1.3       0.245

  Total cholesterol (mg/dL)             153.4 ± 27.8    166.5 ± 33.5    *0.007*

  HDL-c (mg/dL) ^†^                     47.3 ± 12.4     45.7 ± 10.4     0.342

  LDL-c (mg/dL)                         91.0 ± 26.6     100.2 ± 26.4    *0.009*

  Triacylglycerol (mg/dL)               96.1 ± 49.1     103.2 ± 38.5    0.059

  Total cholesterol-to-HDL-c ratio^†^   3.3 ± 0.6       3.8 ± 0.9       *\<0.001*

  Uric acid (mg/dL)                     3.4 ± 1.1       3.7 ± 1.1       *0.049*

  GPx activity (nmol/\[mL/min\])^‡^     487.9 ± 231.3   659.1 ± 299.2   *0.002*

  Selenium (ng/g of nail)^§^            396.2 ± 88.0    365.5 ± 76.7    *0.033*

  Zinc (μg/g of nail)^§^                124.5 ± 57.7    132.3 ± 68.7    0.212

  Copper (μg/g of nail)^§^              7.4 ± 5.5       7.1 ± 7.1       0.247
  -----------------------------------------------------------------------------------

Data are mean ± SD.

Ox-LDL, oxidized low density lipoprotein; BMI, body mass index; ST, skinfold thickness; HOMA-IR, homeostasis model assessment of insulin resistance; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; GPx, glutathione peroxidase.

\*Student *t*test was performed for variables with normal distribution while remaining variables were analyzed by Mann-Whitney *U*test, as appropriate.

\*\*n = 79 and n = 77, for low and high ox-LDL, respectively.

^†^n = 73 for high ox-LDL.

^‡^n = 44 and n = 56, for low and high ox-LDL, respectively.

^§^n = 69 and n = 66, for low and high ox-LDL, respectively.

###### 

Lifestyle features of the participants, categorized by the median (cutoff: 69.4 U/L) of ox-LDL concentrations\*

  ---------------------------------------------------------------------------------------
  *Lifestyle features*               Low ox-LDL\   High ox-LDL\   ***P*- value**^**†**^
                                     \<69.4 U/L\   ≥ 69.4 U/L\    
                                     (n = 80)      (n = 80)       
  ---------------------------------- ------------- -------------- -----------------------
  Vitamin supplement use (%)         6.2           6.2            0.721

  Smokers (%)^‡^                     9.6           13.4           0.105

  Smoking (cigarettes/d)^‡^          1.3 ± 4.9     1.6 ± 4.9      0.318

  Self-reported PA practice (%)^‡^   72.6          70.1           0.116

  MET (h/wk)^‡^                      116 ± 105     135 ± 116      0.324
  ---------------------------------------------------------------------------------------

Ox-LDL, oxidized low density lipoprotein; PA, physical activity; MET, activity metabolic equivalent

\*Data are mean ± SD or frequencies.

^†^*P*-value from *χ*^*2*^test and Mann-Whitney *U*test for dichotomous and continuous variables, respectively.

^‡^n = 73 and n = 67, for low and high ox-LDL, respectively.

To better understand the associations between ox-LDL concentrations and some variables of interest, Sperman\'s coefficient correlations were performed. Although all anthropometric variables presented positive trends with higher ox-LDL values (see Additional file [1](#S1){ref-type="supplementary-material"}: Table S1), only truncal fat significantly correlated with ox-LDL concentration (r~S~= 0.16, *P*= 0.043). Regarding biochemical data and antioxidant defense system components, the following statistical correlations were detected: total cholesterol (r~S~= 0.23, *P*= 0.003), LDL-c (r~S~= 0.22, *P*= 0.004), triacylglicerol (r~S~= 0.013, *P*= 0.013), total cholesterol-to-HDL-c ratio (r~S~= 0.41, P \< 0.001), nail selenium (r~S~= - 0.19, *P*= 0.026) and copper (r~S~= - 0.17, *P*= 0.046) concentrations, and GPx activity (r~S~= 0.29, *P*= 0.003). In addition, systolic blood pressure significantly correlated with ox-LDL concentration (r~S~= 0.17, *P*= 0.027).

In Table [3](#T3){ref-type="table"}, linear regression analysis showed that lipid biomarkers, such as total cholesterol, LDL-c, total cholesterol-to-HDL-c ratio as well as uric acid concentrations and GPx activity were positive predictors of circulating concentrations of ox-LDL, after adjusted for sex, age, smoking status, and physical activity. In turn, nail selenium level was a negative predictive factor of ox-LDL levels. The increase of 1 unit on nail selenium concentration (1 ng/g of nail) was associated with a reduction of 0.06 U/L in ox-LDL circulating levels. The nail copper concentration had a similar effect, but no statistical significance was found.

###### 

Multivariate linear regression analysis with ox-LDL concentrations (U/L) as a dependent variable (n = 160)\*

  Predictors of ox-LDL                   β coefficient (95% CI)      *P*         **R**^**2**^
  -------------------------------------- --------------------------- ----------- --------------
  BMI (kg/m^2^)                          1.206 (-0.347 to 2.760)     0.127       0.008
  Truncal fat (%)                        0.489 (-0.193 to 1.172)     0.158       0.006
  Systolic blood pressure (mmHg)         4.749 (-0.127 to 9.626)     0.056       0.016
  Total cholesterol (mg/dL)              0.228 (0.086 to 0.370)      *0.001*     *0.054*
  LDL-c (mg/dL)                          0.216 (0.048 to 0.384)      *0.012*     *0.033*
  Triacylglycerol (mg/dL)                0.082 (-0.021 to 0.185)     0.118       0.009
  Total cholesterol-to-HDL-c ratio\*\*   15.787 (10.776 to 20.798)   *\<0.001*   *0.198*
  Uric acid (mg/dL)                      4.465 (0.342 to 8.588)      *0.034*     *0.022*
  GPx activity (nmol/\[mL/min\])^†^      0.029 (0.008 to 0.050)      *0.007*     *0.062*
  Selenium (ng/g of nail)^§^             -0.063 (-0.119 to -0.007)   *0.025*     *0.029*
  Copper (μg/g of nail)^§^               -0.573 (-1.322 to 0.176)    0.132       0.009

Ox-LDL, oxidized low density lipoprotein; BMI, body mass index; ST, skinfold thickness; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol,

\*Multivariate linear regressions, adjusted for gender, age, smoking, and physical activity.

\*\*n = 153, ^†^n = 100, ^§^n = 135.

Interestingly, ox-LDL concentrations were higher in the subjects included in the higher tertile of GPx activity (Figure [1](#F1){ref-type="fig"}), independent from gender, age, smoking status, physical activity, truncal fat, uric acid, and total cholesterol concentrations. Also, ox-LDL concentrations were statistically decreased across tertiles of nail selenium values, independent from the same confounding factors (Figure [2](#F2){ref-type="fig"}). When truncal fat was substituted by BMI and total cholesterol was substituted by LDL-c concentration in linear regression models, the same trend and statistical outcomes were found concerning tertiles of GPx activity or nail selenium levels (data not shown). Since we measured the GPx activity and selenium nail levels in fewer number of participants (n = 100 and n = 135, respectively), we *a posteriori*tested the statistical power of the analyses, which was satisfactory for both outcomes (1-β = 0.81 and 1-β = 0.96, respectively).

![**Plasma ox-LDL concentrations (n = 100), according to tertiles of GPx activity**. GPx activity into tertiles, 1st: \<334, n = 33; 2nd: 334-611, n = 34; 3rd: ≥611 nmol/\[mL/min\], n = 33. Data are means and 95% CIs. *P*for trend, from linear regression models adjusted for gender, age, smoking status, physical activity, truncal fat, uric acid and total cholesterol concentrations.](1476-511X-10-61-1){#F1}

![**Plasma ox-LDL concentrations (n = 135), according to tertiles of nail selenium levels**. Nail selenium levels into tertiles, 1st: \<330, n = 45; 2nd: 330-430, n = 45; 3rd: ≥430 ng/g of nail, n = 45. Data are means and 95% CIs. *P*for trend, from linear regression models adjusted for gender, age, smoking status, physical activity, truncal fat, uric acid and total cholesterol concentrations.](1476-511X-10-61-2){#F2}

Finally, the trend of ox-LDL concentrations into tertiles of uric acid was also tested in linear regression model adjusted for gender, age, smoking status, physical activity, truncal fat, and total cholesterol concentrations. Despite the trend was positive, it did not achieve statistical significance (*P*\> 0.05).

Discussion
==========

In this cross-sectional study, ox-LDL concentrations were positively associated with GPx activity and inversely associated with nail selenium levels, both recognized antioxidant markers, in healthy young adults.

GPx is an important antioxidant enzyme, which has been used as oxidative stress marker concerning to an altered antioxidant balance \[[@B4],[@B33]\]. Previous studies have supported the positive predictive effect of GPx activity on circulating levels of ox-LDL \[[@B16],[@B18]\]. Experimental studies showed an increase in the activity of this enzyme in endothelial cells or macrophages treated with ox-LDL, as a protective mechanism against the increased generation of reactive oxygen species induced by ox-LDL \[[@B17],[@B18]\], while other observational study reported also a positive association between GPx activity and ox-LDL in healthy young Spanish adults, despite it was not statistically significant \[[@B16]\]. Thus, our findings are in agreement to the hypothesis that a positive association between GPx activity and ox-LDL might constitute a consequence of the high ox-LDL concentrations, being an adaptive mechanism to prevent further oxidative imbalance.

In turn, our study demonstrated, apparently for the first time, the negative association of nail selenium levels and ox-LDL concentrations, whereas an increase of 1 ng of selenium per g of nail was associated with a decrease of 0.06 U/L in ox-LDL. Selenium is an essential antioxidant mineral, whereas its increased consumption has been inversely associated with pro-inflammatory markers \[[@B34],[@B35]\] as well as with lower hypercholesterolemia \[[@B36],[@B37]\] and lower LDL susceptibility to oxidation \[[@B38]\]. In addition, increased nail selenium levels also have been related to lower pro-inflammatory marker concentrations, such as complement C3 factor, asymmetric dimethylarginine, and interleukin-18 in young healthy adults \[[@B13],[@B14],[@B19]\]. According to previous and onset findings, it could speculate an inverse relationship between dietary selenium intake and the oxidation of LDL-c. Moreover, our finding reinforces the measurement of this mineral in the nail as a promising alternative to assess the relationship of dietary selenium and pro-inflammatory and oxidative stress markers, since it is a good indicator of dietary selenium intake \[[@B39]\], which in turn, has a limited assessment by the scarcity of information in the tables of food composition and by influence of several factor on its bioavailability \[[@B40]\].

Furthermore, ox-LDL was positively associated with other lipid biomarkers, such as total cholesterol and LDL-c, in accordance to previous studies \[[@B7],[@B8],[@B16],[@B41],[@B42]\]. Interestingly, the participants of this study are young adults predominantly normolipidemic (total cholesterol \<200 mg/dL and LDL-c \<160 mg/dL represent 92.5 and 97.5% of the sample, respectively). Thus, it is noteworthy that the increase of 1 mg/dL in serum total cholesterol or in LDL-c as well as of one unit in the total cholesterol-to-HDL-c ratio was predictors of an increment of 0.22; 12.21 and 15.78 U/L in ox-LDL concentrations, respectively. Thus, despite the cross-sectional nature of this study, we could speculate that the positive association between lipid profile and ox-LDL - a recognized oxidative stress marker - occurs early and could explain, at least in the part, the time-course dependent relationships between oxidative stress and chronic disorders in middle-aged and older subjects.

Other relevant outcome of this study was the relationship between uric acid and ox-LDL concentrations, independently of gender, age, smoking status, physical activity, whereas the addition of 1 mg/dL in serum uric acid was associated with the increase of plasma ox-LDL in 4.4 U/L. In this sense, hyperuricemia (≥ 7 mg/dL) has been considered a risk factor for cardiovascular diseases \[[@B9],[@B10],[@B43]\] and a positive predictor of the occurrence of small and dense LDL-c, more susceptible to oxidation \[[@B12]\]. Moreover, uric acid concentration higher than 4 mg/dL appears to have a pro-oxidant redox effect \[[@B11]\], in addition to its synthesis can lead to the generation of superoxide anion radicals, hydroxyl and hydrogen peroxide \[[@B44]\]. The results reported by other authors suggest the role of uric acid in the relationship between oxidative stress and cardiovascular diseases, while the finding of this study might establish a new link of uric acid with oxidative conditions. However, the association between uric acid and ox-LDL was attenuated after adjusting for truncal fat and cholesterol total concentrations, indicating that this relation could be conditioned by other oxidative and metabolic-related risk factors, as previously postulated by other authors \[[@B11],[@B43]\].

Regarding the association of ox-LDL concentrations with anthropometric and body fat distribution data, BMI was significantly higher in those individuals with high ox-LDL, while truncal was significantly positively associated with ox-LDL concentrations. However, both variables were not able to predict to ox-LDL concentrations, which is not in agreement with other studies \[[@B6]-[@B8]\]. In fact, the body fat distribution, characterized by central fat accumulation, has been associated with increasing in pro-inflammatory and oxidative stress markers \[[@B6],[@B23],[@B45]\]. In this context, the lack of associations between concentrations of ox-LDL and adiposity indicators in this study could be explained by the predominance of normal-weight individuals (BMI \<25.0 kg/m^2^; 85% of the sample) or by relatively small size of sample.

Moreover, ox-LDL was not related to glucose biomarkers in young adults. On one hand, some studies have demonstrated the association of hyperglycemia and hyperinsulinemia with increased circulating levels of ox-LDL \[[@B7],[@B41],[@B46]\]. On the other hand, other authors found no significant correlations between circulating levels of ox-LDL and glucose biomarkers \[[@B42],[@B47]\]. Likely, differences in the study sample, such as gender distribution, age, obesity degree or body fat distribution, might influence the outcomes \[[@B4]\].

Our study had certain limitations. The cross-sectional design did not clearly elucidate the cause-and-effect on the results. In addition, the residual confounders that may affect the oxidization of lipoproteins, but were not included in our present study (i.e. dietary factors), should also be considered. Finally, further replication in independent and larger samples would be convenient for a future translational application at a population level, although the sample size is adequate from the standpoint of the initial association discovery, with a satisfactory statistical power in the most relevant analyses of this work.

Conclusions
===========

In summary, ox-LDL concentrations were positively associated with specific lipid biomarkers (total cholesterol, LDL-c and total cholesterol-to-HDL-c ratio), GPx activity and uric acid concentration, and inversely associated with nail selenium levels, independent of different covariates, in young healthy adults. These findings jointly suggest the early and complex relationships between lipid profile and redox status balance, measured through oxidative and antioxidant markers.
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